FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Primitive. Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3442104013 1 (qualifier value) en Fully specified name Active Case insensitive SNOMED CT core
    3442105014 1 en Synonym Active Case insensitive SNOMED CT core
    64719019 One en Synonym Active Case insensitive SNOMED CT core
    771016011 One (qualifier value) en Fully specified name Inactive Initial character case insensitive SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution Count of base of active ingredient False 1 Inferred relationship Some
    Streptokinase 1.5 million unit powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Streptokinase 1.5 million unit powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Cefamandole (as cefamandole nafate) 1 g powder for solution for injection vial Has presentation strength numerator value False 1 Inferred relationship Some 1
    Cefamandole (as cefamandole nafate) 1 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Cefamandole (as cefamandole nafate) 1 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Interferon beta-1a 30 microgram/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Interferon beta-1a 30 microgram/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 3
    Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Levofloxacin anhydrous (as levofloxacin) 25 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Levofloxacin anhydrous (as levofloxacin) 25 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Human chorionic gonadotropin 10000 unit powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Human chorionic gonadotropin 10000 unit powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Chlorhexidine gluconate 500 microgram/mL and tetracaine 150 microgram/mL oral spray Has concentration strength denominator value False 1 Inferred relationship Some 1
    Chlorhexidine gluconate 500 microgram/mL and tetracaine 150 microgram/mL oral spray Has concentration strength denominator value False 1 Inferred relationship Some 2
    Carbidopa anhydrous (as carbidopa) 10 mg and levodopa 100 mg orodispersible tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Carbidopa anhydrous (as carbidopa) 10 mg and levodopa 100 mg orodispersible tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cannabinol 25 mg/mL and tetrahydrocannabinol 27 mg/mL oral spray Has concentration strength denominator value False 1 Inferred relationship Some 2
    Cannabinol 25 mg/mL and tetrahydrocannabinol 27 mg/mL oral spray Has concentration strength denominator value False 1 Inferred relationship Some 1
    Warfarin sodium 5 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Warfarin sodium 5 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefixime anhydrous (as cefixime) 40 mg/mL oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Cefixime anhydrous (as cefixime) 40 mg/mL oral suspension Count of base of active ingredient False 1 Inferred relationship Some
    Mucin 35 mg/mL oral spray Count of base of active ingredient False 1 Inferred relationship Some
    Mucin 35 mg/mL oral spray Has concentration strength denominator value False 1 Inferred relationship Some 1
    Lidocaine hydrochloride 40 mg/mL oropharyngeal solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Lidocaine hydrochloride 40 mg/mL oropharyngeal solution Count of base of active ingredient False 1 Inferred relationship Some
    Blood group antibody D 1136 unit/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Blood group antibody D 1136 unit/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefamandole (as cefamandole nafate) 2 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Cefamandole (as cefamandole nafate) 2 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Somatrem 10 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Somatrem 10 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Carmustine 7.7 mg prolonged-release intralesional implant Has presentation strength denominator value False 1 Inferred relationship Some 1
    Carmustine 7.7 mg prolonged-release intralesional implant Count of base of active ingredient False 1 Inferred relationship Some
    Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Human immunoglobulin G 6 G lyophilised powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Human immunoglobulin G 6 G lyophilised powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Peginterferon alfa-2b 120 microgram powder for solution for injection pen Count of base of active ingredient False 1 Inferred relationship Some
    Peginterferon alfa-2b 120 microgram powder for solution for injection pen Has presentation strength denominator value False 1 Inferred relationship Some 1
    Pituitary follicle stimulating hormone 150 unit and pituitary luteinising hormone 150 unit powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Pituitary follicle stimulating hormone 150 unit and pituitary luteinising hormone 150 unit powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 2
    Peginterferon alfa-2b 80 microgram powder for solution for injection pen Has presentation strength denominator value False 1 Inferred relationship Some 1
    Peginterferon alfa-2b 80 microgram powder for solution for injection pen Count of base of active ingredient False 1 Inferred relationship Some
    Methylprednisolone (as methylprednisolone sodium succinate) 1 g powder for solution for injection vial Has presentation strength numerator value False 1 Inferred relationship Some 1
    Methylprednisolone (as methylprednisolone sodium succinate) 1 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Methylprednisolone (as methylprednisolone sodium succinate) 1 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel Has concentration strength denominator value False 1 Inferred relationship Some 1
    Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel Has concentration strength denominator value False 1 Inferred relationship Some 2
    Amoxicillin anhydrous (as amoxicillin) 200 mg and clavulanic acid (as clavulanate potassium) 28.5 mg chewable tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amoxicillin anhydrous (as amoxicillin) 200 mg and clavulanic acid (as clavulanate potassium) 28.5 mg chewable tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Human C1 esterase inhibitor 500 unit powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Human C1 esterase inhibitor 500 unit powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Doxycycline monohydrate 100 mg orodispersible tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Doxycycline monohydrate 100 mg orodispersible tablet Count of base of active ingredient False 1 Inferred relationship Some
    Sodium cromoglicate 20 mg/actuation powder for inhalation Has presentation strength denominator value False 1 Inferred relationship Some 1
    Sodium cromoglicate 20 mg/actuation powder for inhalation Count of base of active ingredient False 1 Inferred relationship Some
    Cefapirin (as cefapirin sodium) 1 g powder for solution for injection vial Has presentation strength numerator value False 1 Inferred relationship Some 1
    Cefapirin (as cefapirin sodium) 1 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefapirin (as cefapirin sodium) 1 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Dinoprostone 10 mg prolonged-release vaginal pessary Count of base of active ingredient False 1 Inferred relationship Some
    Dinoprostone 10 mg prolonged-release vaginal pessary Has presentation strength denominator value False 1 Inferred relationship Some 1
    Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amoxicillin anhydrous (as amoxicillin) 60 mg/mL oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Amoxicillin anhydrous (as amoxicillin) 60 mg/mL oral suspension Count of base of active ingredient False 1 Inferred relationship Some
    Capsaicin 179 mg cutaneous patch Count of base of active ingredient False 1 Inferred relationship Some
    Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 2
    Sulfasalazine 30 mg/mL rectal suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Sulfasalazine 30 mg/mL rectal suspension Count of base of active ingredient False 1 Inferred relationship Some
    Levonorgestrel 833 nanogram/hour prolonged-release intrauterine drug delivery system Count of base of active ingredient False 1 Inferred relationship Some
    Levonorgestrel 833 nanogram/hour prolonged-release intrauterine drug delivery system Has concentration strength denominator value False 1 Inferred relationship Some 1
    Amoxicillin anhydrous (as amoxicillin) 775 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amoxicillin anhydrous (as amoxicillin) 775 mg prolonged-release oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 2
    Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefazolin (as cefazolin sodium) 20 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefazolin (as cefazolin sodium) 20 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Amoxicillin anhydrous (as amoxicillin) 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amoxicillin anhydrous (as amoxicillin) 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Hexachlorophene 30 mg/mL cutaneous emulsion Has concentration strength denominator value False 1 Inferred relationship Some 1
    Hexachlorophene 30 mg/mL cutaneous emulsion Count of base of active ingredient False 1 Inferred relationship Some
    Mitomycin 40 mg lyophilised powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Mitomycin 40 mg lyophilised powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Lidocaine hydrochloride 40 mg/mL cutaneous solution Count of base of active ingredient False 1 Inferred relationship Some
    Lidocaine hydrochloride 40 mg/mL cutaneous solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Cefmetazole (as cefmetazole sodium) 2 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefmetazole (as cefmetazole sodium) 2 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Mitomycin 5 mg lyophilised powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Mitomycin 5 mg lyophilised powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some

    Start Previous Page 98 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start